CCL2 and breast cancer: TGF-β1-induced activation of MDA-MB-231 and HCC1937 breast cancer cells led to an increase in the activity of the CCL2 promoter in the luciferase reporter system (Fig. 2C), and this was fully provided by its − 244/− 1 region (Fig. 3).